Matt Noestheden

What to expect for cannabis in 2022 and beyond

Feb 1, 2022 | Blogs, Cannabis, Food / Beverage, Food and Beverage | 0 comments

Read time: 2 minutes

As the new year commences and we make plans for 2022, cannabis will be a hot topic in some areas of the world. There may be continuations from 2021 around legislations and regulations, and we might even see new trends for some regions and countries.

Legalization of recreational cannabis in Germany

Let’s first discuss the news that is at the top of my list: legalization of cannabis for recreational use in Germany. In December 2021, Germany welcomed a new chancellor, Olaf Scholz, who has several plans on his agenda, including legalizing cannabis.¹ Currently, it is not illegal to consume cannabis, but it is to buy it. This would make Germany the first major European country to legalize recreational marijuana.²

The parties in the new coalition government agreed to legalize the sale of cannabis to adults if it is sold in licensed establishments where it is properly taxed and quality controlled. Some believe this move will allow Germany to “have a regulated and taxed dispensary, controllable quality and effective youth protection through education.”² However, some of the other parties are not in favor of this. For example, Markus Blume, the party secretary of the CSU, believes it will make a “harmful” drug into a “lifestyle product,” and according to a study, 59% of people say it would be better left the way it has been since 2011.²

Although we can’t say for certain that Olaf Scholz will implement this decision, it will be a hot topic in this year’s cannabis news, so watch for updates.

Cannabis in the US

For most of human history, until the early 20th century, cannabis use was legal in the US. Between 1916 and 1931, however, 29 US states banned the use of marijuana.³ Then came the Marihuana Tax Act of 1937, which was influenced by the Federal Bureau of Narcotics Commissioner at the time, Harry Anslinger and essentially made cannabis illegal across the US.⁴

When we look at the legislation in place today, we can see the legalization of cannabis has started to come full circle across the US. As of July 2021, cannabis had been legalized for recreational use in 18 states and approved for medical use in 37 states.⁵ Given this groundswell of support for medical and recreational cannabis use, might 2022 bring a federal move to legalization? Let’s take a look.

Back in September 2021, a key committee in the US House of Representatives approved a bill to federally legalize marijuana with an aim of promoting social equity.⁶ While federal cannabis legalization does not appear to be a priority for the Biden administration, efforts continue in the House and the US Senate to bring federal policy closer in line with state laws. With these efforts ongoing, and with 60% of adults believing that cannabis should be legal for both medical and recreational use⁷, might 2022 be the year we see federal legalization?

References

Kirby, J. Germany’s new government has big plans. It might be a shock after Merkel. Vox, December 8, 2021. https://www.vox.com/2021/12/8/22810520/germany-government-olaf-scholz-chancellor-greens-fdp
Schuetze, C.F. The new German government plans to legalize Cannabis. The New York Times, November 24, 2021. https://www.nytimes.com/2021/11/24/world/europe/german-government-cannabis.html
Speights, K. A Guide to Marijuana Legalization in the United States. The Motley Fool, November 29, 2021. https://www.fool.com/investing/stock-market/market-sectors/healthcare/marijuana-stocks/marijuana-legalization/
US Customs and Border Protection: Did You Know… Marijuana Was Once a Legal Cross-Border Import? Last modified December 20, 2019. https://www.cbp.gov/about/history/did-you-know/marijuana
Hupka, S. Senate moves to legalize pot at federal level. What are the chances? Los Angeles Times, July 29, 2021. https://www.latimes.com/politics/story/2021-07-29/what-are-the-chances-senate-will-legalize-pot-marijuana
Jaeger, K. Bill To Federally Legalize Marijuana Approved By Key House Committee. Marijuana Moment, September 30, 2021. https://www.marijuanamoment.net/watch-live-key-house-committee-to-vote-on-federal-marijuana-legalization-bill/
Malyshev, A.; Ganley, S. Reading the tea leaves: What might federal legalization of marijuana look like? Reuters, November 15, 2021. https://www.reuters.com/legal/litigation/reading-tea-leaves-what-might-federal-legalization-marijuana-look-like-2021-11-15/

RUO-MKT-18-14262-A

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

Matt Noestheden

Matt is the Market Development Manager for the Cannabis, Food and Environmental markets in the Americas at SCIEX. Matt brings 15 years of LC-MS experience to this role, spanning the pharmaceutical, environmental, food and cannabis industries. Matt loves talking about all things mass spectrometry, so reach out if you have any questions at matt.noestheden@sciex.com.

0 Comments